University of Miami's 2nd Biennial Miami Leukemia Symposium


 

Discussion on the Data of Frontline Combination Therapy with APR-246 + Azacitidine in TP53 MT HMA-naive MDS and Oligoblastic AML

19 views
May 14, 2020
0 Comments
Login to view comments. Click here to Login